Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis

S A Prasad1, E Main, M E Dodd

  • 1Cystic Fibrosis Unit, Great Ormond Street Hospital for Children, London, UK. prasaa@gosh.nhs.uk

Pediatric Pulmonology
|January 25, 2008
PubMed

Insights

Expert consensus on physiotherapy for babies with cystic fibrosis (CF) found agreement on most management aspects. However, routine daily chest physiotherapy for asymptomatic infants remains debated, allowing flexible approaches.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiotherapy
  • Cystic Fibrosis Management

Background:

  • Neonatal screening identifies babies with cystic fibrosis (CF) who often lack early respiratory symptoms.
  • The necessity of traditional daily chest physiotherapy for these asymptomatic infants is debated internationally.
  • Current evidence is lacking, and practical challenges prevent large-scale trials in the UK.

Purpose of the Study:

  • To establish expert consensus on physiotherapy management for infants diagnosed with CF via neonatal screening.
  • To address the uncertainty surrounding the role of chest physiotherapy in asymptomatic CF infants.

Main Methods:

  • A Delphi consensus method was employed, involving senior pediatric physiotherapists across the UK.
  • Experts reviewed and voted on 16 statements concerning physiotherapy for asymptomatic infants with CF.

Main Results:

  • High consensus (15/16 statements) was achieved among 25 participating physiotherapists.
  • Consensus failed on whether to routinely initiate daily chest physiotherapy for asymptomatic infants.
  • An amended statement allows flexibility in treatment initiation based on clinical judgment.

Conclusions:

  • Senior UK physiotherapists largely agree on managing infants with CF.
  • There is no consensus on the routine need for daily chest physiotherapy in asymptomatic CF infants.
  • The findings will inform national clinical guidelines for CF physiotherapy, allowing adapted practices.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...